Capricor Therapeutics
CAPR
CAPR
16 hedge funds and large institutions have $2.44M invested in Capricor Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.98M | |
| 2 | +$150K | |
| 3 | +$56K | |
| 4 |
Morgan Stanley
New York
|
+$12.7K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$2K |
Top Sellers
| 1 | -$69K | |
| 2 | -$1.17K | |
| 3 | -$471 | |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$30 |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7 |